IPMPC White Paper: The Evolving Ethical and Legal Framework for the Use of AI in the Pharmaceutical and Medical Device Industries 


21 Dec 2020

EFPIA-IPMPC Comments on EDPB Recommendations

21 Dec 2020

Importance of Transatlantic Data Flows to Healthcare Innovation and Delivery

19 Oct 2020

EFPIA-IPMPC Submission to EDPB Regarding Controller-Processor Guidelines

23 Jul 2020

Personal Data’s Role in Advancing Health Care Innovation

10 Jul 2020

IPMPC Submission on EMA Discussion Paper for Medicines Developers, Data Providers, Research-Performing and Research-Supporting Infrastructures on GDPR and Secondary Use of Data for Medicines and Public Health Purposes

17 Apr 2020

IPMPC Comments on EDPS Preliminary Opinion on Scientific Research Purposes

27 Mar 2020

IPMPC Comments on Version 3 of Revised CCPA Proposed Regulations

25 Feb 2020

IPMPC Comments on Revised CCPA Regulations

17 Dec 2019

IPMPC Comments to the California Attorney General re Proposed CCPA Regulations

08 Apr 2019

IPMPC White Paper on the Role of Personal Data in Healthcare

08 Apr 2019

IPMPC Principles for US Privacy Legislation

08 Mar 2019

IPMPC Comments to California Attorney General re CCPA Regulations

Over the last century, medical science has transformed human health and dramatically increased life expectancy. The life saving treatments available today were made possible by an environment that fostered medical research. The scientific process used in medical research relies on the ability to effectively collect, analyze and reanalyze patient health information. Pharmaceutical companies collect patient health information created in controlled research settings (e.g., clinical trials to investigate an experimental drug), as well as real world patient health data.

© 2019 International Pharmaceutical & Medical Device Privacy Consortium

Contact us at